#USA #Boston #Life Sciences #Supply Chain #TraceLink

Overview of TraceLink's Strategy for 2026

As the life sciences sector steps into 2026, TraceLink has set forth an ambitious direction aimed at refining the orchestration of supply chains globally. With the industry facing challenges such as regulatory complexities, global uncertainties, and the rapid pace of artificial intelligence adoption, the need for robust, seamless operations has never been more critical.

Shabbir Dahod, President and CEO of TraceLink, emphasized the opportunity presented by digital transformation in one of the most vital yet least automated industries. He stated, "The operational deployment of AI across the life sciences represents a generational opportunity, paving the way for a highly orchestrated and efficient supply chain."

Achievements in 2025

Reflecting on the past year, TraceLink reported significant milestones. In 2025, they successfully executed the U.S. Drug Supply Chain Security Act (DSCSA) compliance, marking a crucial regulatory accomplishment. This involved:

• - Activating approximately 300 new DSCSA live links weekly.
• - Processing billions of serialized transaction events with enterprise-grade performance.
• - Connecting a vast network of manufacturers, wholesalers, dispensers, and third-party logistics providers.

The completion of the DSCSA initiative not only ensured compliance but also established a robust foundation for digital transformation in supply chain processes. The strengthened infrastructure supports a shift from mere connectivity to scaled operational execution among TraceLink’s 310,000+ trading partners.

Evolution of the TraceLink Network

In 2025, the network's focus shifted significantly, moving beyond compliance-based functionalities to embrace full-scale orchestration of supply chain outcomes. With over 339,000 active links and more than 1,790 users, customers are leveraging TraceLink's capabilities for diverse applications:

• - 971% year-over-year growth in newly connected MINT links.
• - Launching 21 new workflows encompassing logistics, manufacturing, and commercial operations.
• - Supporting over 7 billion regulated transactions annually.

This transformation underscores the “network-is-the-product” model, wherein increased connectivity leads to enhanced transaction efficiency and reduced operational complexities.

Accelerated MINT Adoption

TraceLink's flagship Multienterprise Information Network Tower (MINT) witnessed unprecedented growth in 2025, with:

• - 59% increase in MINT customers year-on-year.
• - 584% growth in onboarding MINT links.

This growth demonstrates a strategic move toward network-based orchestration not limited to compliance but extending into critical business functions like production, inventory management, and financial settlements.

Enhancements in OPUS

TraceLink has also expanded its Orchestration Platform for Universal Solutions (OPUS) significantly. In 2025, OPUS introduced:

• - 60+ standardized transaction types.
• - 65+ collaborative multienterprise processes.
• - Advanced no-code tools to facilitate easy customization and orchestration of processes.

The upgrades establish a solid operational foundation that is essential for agentic operations in supply chain management.

Recognition and Industry Trust

As TraceLink deepens its network capabilities, independent evaluations have echoed its reputation as a trusted leader in digital supply chain management. Their achievements include:

• - Multiple ISO certifications and AICPA attestations.
• - Recognition as a Leader in IDC's MESCCN Vendor Assessment.

These validations highlight TraceLink's commitment to reliability and governance in the domain of life sciences supply chain management.

Looking Ahead to 2026

With a robust infrastructure and a trusted network already in place, TraceLink is poised to take significant strides in 2026, scaling agentic orchestration throughout global health supply chains. The transition from compliance-focused strategies to real-time actionable intelligence signifies a new era for digital transformation in life sciences. By embedding OPUS Agents into their networked transactions, TraceLink is set to empower real-time actions based on trusted data and interconnected workflows.

In conclusion, 2026 promises to be a pivotal year for TraceLink and the life sciences industry as they harness the potential for more intelligent and responsive supply chain operations.